Acute Porphyria Drugs

Monograph

D07AB02 - Hydrocortisone Butyrate
Propably not porphyrinogenic
PNP

Rationale
Probably only insignificant absorption. Ligand to PXR. Substrate for CYPs 3A4, 3A7, 11 B2. Inducer and inhibitor (!) of CYP 3A4. Several references stating non-porphyrinogenicity of glucocorticoids.
Chemical description
Moderately strong glucocorticoid ointment 0,1 % used in dermatology. Risk for some systemic exposure in application on large areas of the body. Glucocorticoid: South African list: use. Kalman, Bonkovsky: believed to be safe. The Merck Manual: use. Moore MR, Hift RJ: Drugs in acute porphyria. Cell Mol Biol 43:89, 1997: safe. Tschudy DP, Lamon JM: Porphyrin metabolism and the Porphyrias in Bondy BK, Rosenberg LE (eds): Duncan’s Diseases of Metabolism, Philadelphia, WB Saunders 1980, p 939: safe.
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes D07A / D07AB or go back.
References
Tradenames

Locoid Locoid · Locoid Lipocreme Laticort · Locoid Locoid Locoid Hydrocortisone butyrate 0.1% ointment 10% in Hydrous ointment · Locoid · Locoid Crelo Locoid Alfason · Locoid Laticort · Locoid Locoid · Locoid Lipocreme Locoid Bucort · Locoid Laticort Laticort Locoidon Hydrocortisone butyrate · Locoid · Locoid c
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙